Abravanel, Daniel L <br/><br/>
An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  08 2018 
 - e131-e133 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1016/j.jtho.2018.03.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma of Lung--drug therapy<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Imidazoles--therapeutic use<br/>Lung Neoplasms--drug therapy<br/>Middle Aged<br/>Mutation<br/>Oximes--therapeutic use<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Pyridones--therapeutic use<br/>Pyrimidinones--therapeutic use